GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $42,000 | -61.1% | 89,296 | +30.4% | 0.00% | – |
Q3 2015 | $108,000 | -7.7% | 68,465 | -0.4% | 0.00% | – |
Q2 2015 | $117,000 | +515.8% | 68,747 | +402.2% | 0.00% | – |
Q1 2015 | $19,000 | -20.8% | 13,688 | -15.2% | 0.00% | – |
Q4 2014 | $24,000 | -50.0% | 16,150 | -30.1% | 0.00% | – |
Q3 2014 | $48,000 | -21.3% | 23,106 | -4.7% | 0.00% | – |
Q1 2014 | $61,000 | -50.8% | 24,241 | -2.7% | 0.00% | – |
Q4 2013 | $124,000 | – | 24,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
Thomasville National Bank | 95,000 | $195,000 | 0.08% |
SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |